ABNB · NASDAQ-GS
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Total Revenue | $12.24B | $11.10B | $9.92B | $8.40B | $5.99B | $3.38B | $4.81B |
| Cost of Revenue | $2.09B | $1.88B | $1.70B | $1.50B | $1.16B | $876.00M | $1.20B |
| Research & Development | $2.35B | $2.06B | $1.72B | $1.50B | $1.43B | $2.75B | $976.70M |
| Selling, General & Administrative | $1.34B | $1.19B | $2.02B | $950.00M | $836.00M | $1.14B | $697.18M |
| Operating Expenses | $9.70B | $8.55B | $8.40B | $6.60B | $5.56B | $6.97B | $5.31B |
| Operating Income | $2.54B | $2.55B | $1.52B | $1.80B | $429.00M | -$3.59B | -$501.54M |
| Other Income / (Expense) | -$112.00M | -$40.00M | -$137.00M | $1.00M | -$304.00M | -$947.00M | $13.91M |
| Income Before Taxes | $3.14B | $3.33B | $2.10B | $1.99B | -$300.00M | -$4.68B | -$411.70M |
| Provision for Income Taxes | $626.00M | $683.00M | -$2.69B | $96.00M | $52.00M | -$97.00M | $262.64M |
| Net Income | $2.51B | $2.65B | $4.79B | $1.89B | -$352.03M | -$4.58B | -$674.34M |
| Basic Shares Outstanding | 613.00M | 632.00M | 637.00M | 637.00M | 616.00M | 284.00M | 260.56M |
| Diluted Shares Outstanding | 623.00M | 645.00M | 662.00M | 680.00M | 616.00M | 284.00M | 260.56M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $4.93 | $3.98 | $5.21 | 13 | ↑1 ↓1 |
| Dec 2027 | $5.90 | $5.35 | $7.58 | 13 | ↑1 ↓0 |
| Dec 2028 | $7.04 | $5.98 | $9.65 | 6 | ↑0 ↓0 |
| Dec 2029 | $9.36 | $6.81 | $12.73 | 3 | ↑0 ↓0 |